End of 2017…
Mkt cap 26m
Net cash 0.5m
Enterprise value 25.5m
Sales 15m
Ebitda -0.6m
Today…
Mkt cap 134m
Net cash 101m
Enterprise value 33m
Sales 96m
Ebitda 36m
Enterprise value is what you should look at as it adjust for cash!!!!!!
So this business is now worth 7.5m more than we were in 2017.
If you didnt laugh you would cry.
Gift. Horse. Mouth.
Bye bye spivvy financially illiterate dream chasers. Sellsell sell and move on.
Newbee at 110p….
Ncyt have 70.6m shares outstanding. Therefore the mkt cap at 110p would be 77.66m
Do you think that a company with 101m of cash can be worth less than the value of the cash it has on its balance sheet to the tune of 23m.
Me thinks you don’t have a ticking clue what you are on about. Do you?
A pound is worth…..a pound. What you suggest is that a pound held by Novacyt is worth 77p.
Even if you do t like Novacyt is there cash not worth the same as everyone else cash?
The absolute floor here is the cash value the company has. At the moment that is 101m. That equates to a share price of 1.43. So not far from where we are.
Gift. Horse. Face.
Ignore assets. That just accounting.
The only thing you need to know is enterprise value = mkt cap minus cash
So at the moment the enterprise value is less than 40m. That is to say if someone wanted to buy Novacyt it would cost them 40m only.
Beyond ridiculous. Just added.
I keep reading that 140m market cap is ridiculous on here this morning. You need to put that in the context of what the market is actually valuing the equity value of given the cash pile. Eg cash is worth…..cash.
So strip that from the market cap to get what the market is really valuing this equity at. Yeh that right….40m.
Whether you hate this company or not or believe covid is done. No one can argue a case that this business was is not worth more than 40m equity value. No one.
Why is no one picking up the comment re m&a n the rns? Small companies with 100m on the balance sheet dont just sit there and cuddle that 100m.
We could make an acquisition of a company adding another 10m of ebitda with a click of the fingers. Do people just think that 100m sits there forever and we don’t invest it?
I don’t agree. The mkt for Novacyt shares is distorted by a large holding of get rich quick Financially illiterate spivs at moment. They are now selling. That is a good thing. This stock needs that so badly. It needs investors not dream chasers.
Hopefully this will get rid of the covid get rich quick dream chasers. This stock needs that money to leave. That’s over.
When that happens you will get some normality return and people will start to value what is left. And what is left? 100m of cash optionality. A good reputation. A strong global footprint. Decent product suite with innovation and the heart.
IMO that investible as they have so much optionality here to be ambitious.
To all the financially illiterate, get rich quick on the aim casino muppets….bye bye. You won’t be missed. Go back to Bitcoin.
To everyone else. You are left with a company with 100m of cash, a new ceo, a new strategy, a company trading at 1.8x this years ebitda and 3.6x next years. If any of the future strategy enables this company to maintain a 20-30m ebitda beyond 2022 and going forward without burning all the cash then this stock is going to be meaningfully higher.
This IS the end of covid. This IS the beginning for Novacyt.
Sales are vanity. Profit is sanity. Cash is reality.
This really is all you need to know here.
If ncyt was a new shell company that had 101m of cash and a dream to create a diagnostics biz…with no products, no sales team, no reputation, no expertise etc etc …..it would be worth more than it currently is.
Net debt is net cash. So that negative 101m
Mkt cap is 168m
So the enterprise value here is 67m
At current ebitda that’s trading at 1.8x ebitda. Assume ebitda halves next year to say 18m. That’s 3.7x ev ebitda.
The sector average is probably 15-30x ev ebitda.
2022 is always the inflection year post covid. It will rebound heavily after 2022 as new non covid business evolves.
People should be happy with this rns. A strategy is born.
Also worth noting asos mkt cap is £2.26bn so on main market they will be ftse 250 at the next roll. As a result every ftse 250 tracker fund and ETF is a forced buyer of asos shares.
Same would be true if boo went main market. This is a GREAT move by asos and one we should 100% follow.
Genuinely think the AIM is a toilet which Facilitates shoddy and often illegal management practices and lies with little accountability. You n the investor side it’s a boom or bust **** show full of get rich quick, herd investing spivs and financially illiterate dream chasers. There is no reason any company with nothing to hide would not seek a more diverse, knowledgable, sophisticated and deeper pocketed investor base away from the aim sewer. …. Unless you did not want to be held accountable for the bull**** you spout on your RNS and earnings announcements.
ASOS and boo have outgrown this cess pit.